Medullary Thyroid Carcinoma — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Plasma metanephrines and serum calcium/PTH
Medullary thyroid carcinoma (MTC) can be sporadic (~75%) or part of MEN2 syndrome (~25%). ALL patients with MTC must have plasma free metanephrines (to exclude concurrent phaeochromocytoma – which must be operated on FIRST to prevent intraoperative hypertensive crisis) and serum calcium/PTH (to exclude hyperparathyroidism – MEN2A). RET proto-oncogene testing should also be performed. Thyroglobulin is a marker for differentiated (papillary/follicular) thyroid cancer, NOT medullary.
Reference: eTG – 2025 – Endocrinology; ATA – 2015 – MTC Management Guidelines